Circ-ADAM9 was found to participate in breast cancer progression through targeting the miR-383-5p/PFN2 axis.
Knockdown of circ-ADAM9 inhibits malignant phenotype and enhances radiosensitivity in breast cancer cells via acting as a sponge for miR-383-5p.